United States· US:70709-085_8716de8d-f4b6-4192-892c-cb22b511257c
ORMALVI
A medicinal product containing dichlorphenamide, registered in United States by Cycle Pharmaceuticals Ltd..
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- DICHLORPHENAMIDE
- Manufacturer
- Cycle Pharmaceuticals Ltd.
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc117070908510100 TABLET in 1 BOTTLE (70709-085-10)
- ndc1170709-085-10
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Dichlorphenamide in 2 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/31518ea9-9c01-434e-824b-8466de2010c7 GET /v1/drugs/31518ea9-9c01-434e-824b-8466de2010c7?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "50",
"substance": "DICHLORPHENAMIDE",
"productndc": "70709-085",
"dosage_form": "TABLET",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": "ANDA215924",
"marketing_category": "ANDA"
}See everything about dichlorphenamide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.